Statin Selection and Management

Introduction to Statin Classes

Both hydrophilic and lipophilic statins effectively reduce LDL cholesterol and cardiovascular events, with some nuanced differences, according to the American College of Cardiology 1
The American College of Cardiology recommends considering the properties of hydrophilic and lipophilic statins, including their solubility, tissue penetration, and metabolism, when selecting a statin for patients 1

Hydrophilic and lipophilic statins reduce LDL-C by 18-55% depending on dose, with rosuvastatin (hydrophilic) being generally more potent on a milligram-to-milligram basis, as stated by the American College of Cardiology 1
Both classes demonstrate significant reductions in myocardial infarctions, revascularization procedures, stroke, and peripheral vascular disease, according to the American College of Cardiology 1

Lipophilic statins have a generally higher risk of myopathy and rhabdomyolysis, with greater tissue penetration contributing to muscle-related adverse effects, as reported by the American College of Cardiology 1
Hydrophilic statins have a lower incidence of muscle-related side effects, making them a preferable option for patients with a history of muscle symptoms, according to the American College of Cardiology 1
The American College of Cardiology notes that lipophilic statins are more susceptible to drug interactions, particularly with medications metabolized by CYP3A4, and have a higher risk when combined with fibrates, especially gemfibrozil 1

Advanced age (≥65 years) is a risk factor for statin-associated myopathy, and hydrophilic statins may be preferred in elderly patients due to lower risk of myopathy, as stated by the American College of Cardiology 1
Pitavastatin (lipophilic but with unique properties) may have less impact on glucose metabolism compared to other statins, according to the American College of Cardiology 3
The American College of Cardiology recommends that all statins should be discontinued 1-2 months before planned pregnancy, and if pregnancy is unplanned, statins should be stopped immediately, especially for women of childbearing potential 2

The American College of Cardiology recommends preferring hydrophilic statins (rosuvastatin, pravastatin) for patients with high risk of drug interactions 1
For patients with a history of muscle symptoms, the American College of Cardiology suggests considering hydrophilic statins first, and pitavastatin may be an alternative option for patients with statin intolerance 3
The American College of Cardiology advises adjusting doses of hydrophilic statins accordingly and monitoring more closely for adverse effects in patients with renal impairment 1